ivermectin
| 5 min read
Pre-screening of the gut microbiome may lead to a more personalized approach to treating intestinal parasitic worm infections, leading to better treatment outcomes and a decreased risk for drug resistance.
| 3 min read
Before its COVID-19 era hype, ivermectin was already a wonder drug for parasitic infections. Its renewed interest underscores the need for effective COVID-19 treatments and communication on proper research study design and analysis.
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
Preparing data for AI/ML predictive modeling
Mastering data preparation is key to harnessing the full potential of advanced computational tools.
A Technology Guide for CRISPR Screening
Emerging CRISPR screening methods are shaping what’s possible in drug development and precision medicine.
